Skip to main content
SpringerLink
Log in

Trigger Point Injections for Pelvic Pain

  • Chapter
  • First Online:
Office-Based Gynecologic Surgical Procedures

  • 990 Accesses

Abstract

Chronic pelvic pain is one of the most challenging problems gynecologists encounter in clinical practice. Although management often involves a combination of medical, physical, cognitive, and behavioral therapies, trigger point injections offer an additional option for treatment in a subset of patients. This office-based procedure has been used to improve pain associated with vaginismus, levator ani hypertonicity, vulvodynia, pudendal and ilioinguinal/iliohypogastric neuralgia. In this textbook chapter we review various injections used to treat pelvic pain, summarize the evidence for their use, and describe their role in treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mathias SD, Kuppermann M, Liberman RF, Lipschutz RC, Steege JF. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol. 1996;87:321–7.

    Article  PubMed  CAS  Google Scholar 

  2. Jamieson DJ, Steege JF. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol. 1996;87:55–8.

    Article  PubMed  CAS  Google Scholar 

  3. Ling FW, Slocumb JC. Use of trigger point injections in chronic pelvic pain. Obstet Gynecol Clin North Am. 1993;20(4):809–15.

    PubMed  CAS  Google Scholar 

  4. Langford CF, Udvari NS, Ghoniem GM. Levator ani trigger point injections: an underutilized treatment for chronic pelvic pain. Neurourol Urodyn. 2007;26(1):59–62.

    Article  PubMed  Google Scholar 

  5. Moldwin RM, Fariello JY. Myofascial trigger points of the pelvic floor: associations with urological pain syndromes and treatment strategies including injection therapy. Curr Urol Rep. 2013;14(5):409–17. doi:10.1007/s11934-013-0360-7.

    Article  PubMed  Google Scholar 

  6. Abbott JA. The use of botulinum toxin in the pelvic floor for women with chronic pelvic pain—a new answer to old problems? J Minim Invasive Gynecol. 2009;16(2):130–5.

    Article  PubMed  Google Scholar 

  7. Jabbari B. Botulinum neurotoxins in the treatment of refractory pain. Nat Clin Pract Neurol. 2008;4(12):676–85.

    Article  PubMed  CAS  Google Scholar 

  8. Cui K, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain. 2004;107:125–33.

    Article  PubMed  CAS  Google Scholar 

  9. Criscuolo CM. Interventional approaches to the management of myofascial pain syndrome. Curr Pain Headache Rep. 2001;5:407–11.

    Article  PubMed  CAS  Google Scholar 

  10. Jarvis SK, Abbott JA, Lenart MB, Steensma A, Vancaille TG. Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles. Aust N Z J Obstet Gynaecol. 2004;44:46–50.

    Article  PubMed  Google Scholar 

  11. Romito S, Bottanelli M, Pellegrini M, Vicentini S, Rizzuto N, Bertolasi L. Botulinum toxin for the treatment of genital pain syndromes. Gynecol Obstet Invest. 2004;58:164–7.

    Article  PubMed  CAS  Google Scholar 

  12. Bertolasi L, Frasson E, Cappelletti JY, Vicentini S, Bordignon M, Graziottin A. Botulinum neurotoxin type a injections for vaginismus secondary to vulvar vestibulitis syndrome. Obstet Gynecol. 2009;114(5):1008–16.

    Article  PubMed  CAS  Google Scholar 

  13. Abbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaille TG. Botulinum toxin type A for chronic pain and pelvic floor spasm in women. Obstet Gynecol. 2006;108(4):915–22.

    Article  PubMed  Google Scholar 

  14. Park AJ, Paraiso MFR. Successful use of botulinum toxin type A in the treatment of refractory postoperative dyspareunia. Obstet Gynecol. 2009;114:484–7.

    Article  PubMed  Google Scholar 

  15. Abbott J. Gynecological indications for the use of botulinum toxin in women with chronic pelvic pain. Toxicon. 2009;54:647–53.

    Article  PubMed  CAS  Google Scholar 

  16. Allergan, Inc 2013. Highlights of prescribing information. Accessed from: http://www.allergan.com/assets/pdf/botox_pi.pdf

  17. The American College of Obstetricians and Gynecologists. Practice bulletin #119: Female sexual dysfunction. 2011. http://www.acog.org/Resources-And-Publications/Practice-Bulletins/Committee-on-Practice-Bulletins-Gynecology/Female-Sexual-Dysfunction

  18. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed (Text rev). Washington, DC: APA; 2000.

    Google Scholar 

  19. Dykstra DD, Presthus J. Botulinum toxin type A for the treatment of provoked vestibulodynia: an open-label, pilot study. J Reprod Med. 2006;51(6):467–70.

    PubMed  CAS  Google Scholar 

  20. Yoon H, Chung WS, Shim BS. Botulinum toxin A for the management of vulvodynia. Int J Impot Res. 2007;19:84–7.

    Article  PubMed  CAS  Google Scholar 

  21. Petersen CD, Giraldi A, Lundvall L, Kristensen E. Botulinum toxin type A—a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double-blinded study. J Sex Med. 2009;6(9):2523–37.

    Article  PubMed  CAS  Google Scholar 

  22. Lange O, Bigalke H, Dengler R, Wegner F, deGroot M, Wohlfarth K. Neutralizing antibodies and secondary therapy failure after treatment with botulinum toxin type A: much ado about nothing? Clin Neuropharmacol. 2009;32:213–8.

    Article  PubMed  CAS  Google Scholar 

  23. Ghazizadeh S, Nikzad M. Botulinum toxin in the treatment of refractory vaginismus. Obstet Gynecol. 2004;104:922–5.

    Article  PubMed  CAS  Google Scholar 

  24. Fortuna R, Vaz MA, Youssef AR, Longino D, Herzog W. Changes in contractile properties of muscles receiving repeat injections of botulinum toxin. J Biomech. 2011;44:39–44.

    Article  PubMed  Google Scholar 

  25. Nesbitt-Haws EM, Won H, Jarvis SK, Lyons SD, Vancaillie TG, Abbott JA. Improvement in pelvic pain with botulinum toxin type A—single vs. repeat injections. Toxicon. 2013;63:83–7.

    Article  Google Scholar 

  26. Benson JT, Griffis K. Pudendal neuralgia, a severe pain syndrome. Am J Obstet Gynecol. 2005;192:1663–8.

    Article  PubMed  Google Scholar 

  27. McDonald JS, Spigos DG. Computed tomography-guided pudendal block for treatment of pelvic pain due to pudendal neuropathy. Obstet Gynecol. 2000;95:306–9.

    Article  PubMed  CAS  Google Scholar 

  28. Hough DM, Wittenberg KH, Pawline W, Mause TP, King BF, Vrtiska TJ, Farrell MA, Antolak SJ. Chronic perineal pain caused by pudendal nerve entrapment: anatomy and CT-guided perineural injection technique. AJR Am J Roentgenol. 2003;181(2):561–7.

    Article  PubMed  Google Scholar 

  29. Peng PW, Tumber PS. Ultrasound-guided interventional procedures for patients with chronic pelvic pain—a description of techniques and review of the literature. Pain Physician. 2008;11(2):214–24.

    Google Scholar 

  30. Whiteside JL, Barber MD, Walters MD, Falcone T. Anatomy of ilioinguinal and iliohypogastric nerves in relation to trocar placement and low transverse incisions. Am J Obstet Gynecol. 2003;189:1574–8.

    Article  PubMed  Google Scholar 

  31. Bell EA, Jones BP, Olufolabi AJ, Dexter F, Phillips-Bute B, Greengass RA, Penning DH, Reynolds JD. Iliohypogastric-ilioinguinal peripheral nerve block for post-cesarean delivery analgesia decreases morphine use but not opioid-related side effects. Can J Anaesth. 2002;49(7):694–700.

    Article  PubMed  Google Scholar 

  32. Wehbe SA, Ghulmiyyah LM, Dominique EH, Hosford SL, Ehleben CM, Saltzman SL, Sills ES. Prospective randomized trial of iliohypogastric-ilioinguinal nerve block on post-operative morphine use after inpatient surgery of the female reproductive tract. J Negat Results Biomed. 2008;7:11. doi:10.1186/1477-5751-7-11.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Female Pelvic Medicine and Reconstructive Surgery, MedStar Washington Hospital Center/Georgetown University School of Medicine, Washington, DC, 20010, USA

    Jeannine M. Miranne M.D. & Amy J. Park M.D.

Authors
  1. Jeannine M. Miranne M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amy J. Park M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeannine M. Miranne M.D. .

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecolog, Cleveland Clinic, Willoughby Hills, Ohio, USA

    Jonathan D. Emery

  2. Department of Obstetrics and Gynecology, Cleveland Clinic, Cleveland, Ohio, USA

    Marie Fidela R. Paraiso

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Miranne, J.M., Park, A.J. (2015). Trigger Point Injections for Pelvic Pain. In: Emery, J., Paraiso, M. (eds) Office-Based Gynecologic Surgical Procedures. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1414-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1414-2_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1413-5

  • Online ISBN: 978-1-4939-1414-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation